Additionally, Swarbrick M. M. et al. demonstrated that treatment with IONIS 113715 could reduce PTP1B expression in insulin-sensitive tissues in monkeys, resulting in significant improvements in insulin sensitivity, reduction in fasting insulin concentrations, and prevention of insulin resistance and T2DM associated with obesity [109]. Here, PTPN1 is linked to obesity disorder.